Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

doi:10.1016/J.TUBE.2018.07.005

Title: Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

Full Record
Other Related Research

Abstract

Here, the monitoring of TB treatments in clinical practice and clinical trials relies on traditional sputum-based culture status indicators at specific time points. Accurate, predictive, blood-based protein markers would provide a simpler and more informative view of patient health and response to treatment. We utilized sensitive, high throughput multiplexed ion mobility-mass spectrometry (IM-MS) to characterize the serum proteome of TB patients at the start of and at 8 weeks of rifamycin-based treatment. We sought to identify treatment specific signatures within patients as well as correlate the proteome signatures to various clinical markers of treatment efficacy. Serum samples were collected from 289 subjects enrolled in CDC TB Trials Consortium Study 29 at time of enrollment and at the end of the intensive phase (after 40 doses of TB treatment). Serum proteins were immunoaffinity-depleted of high abundant components, digested to peptides and analyzed for data acquisition utilizing a unique liquid chromatography IM-MS platform (LC-IM-MS). Linear mixed models were utilized to identify serum protein changes in the host response to antibiotic treatment as well as correlations with culture status end points. A total of 10,137 peptides corresponding to 872 proteins were identified, quantified, and used for statistical analysis across the longitudinal patient cohort.more »« less

Authors:

Kedia, Komal ^[1]; Wendler, Jason ^[1];

^[1]; Burnum-Johnson, Kristin E. ^[1];

^[2]; Stratton, Kelly G. ^[3];

^[1];

^[1]; Gritsenko, Marina A. ^[1]; Lewinsohn, David M. ^[4]; Sigal, George B. ^[5]; Weiner, Marc H. ^[6]; Smith, Richard D. ^[1]; Jacobs, Jon M. ^[1];

^[2]

Pacific Northwest National Lab. (PNNL), Richland, WA (United States). Biological Sciences Division and Environmental Molecular Sciences Lab.
Univ. of California San Francisco, San Francisco, CA (United States). Div. of Pulmonary and Critical Care Medicine
Pacific Northwest National Lab. (PNNL), Richland, WA (United States). Computational and Statistical Analysis Div.
Oregon Health & Science Univ., Portland, OR (United States). Pulmonary and Critical Care Medicine
Meso Scale Diagnostics, Rockville, MD (United States)
Univ. of Texas Health Science Center at San Antonio and the South Texas VAMC, San Antonio, TX (United States)

Publication Date:: 2018-07-18

Research Org.:: Pacific Northwest National Lab. (PNNL), Richland, WA (United States)

Sponsoring Org.:: USDOE

OSTI Identifier:: 1461904

Alternate Identifier(s):: OSTI ID: 1461645

Report Number(s):: PNNL-SA-126570
Journal ID: ISSN 1472-9792; PII: S1472979218301264

Grant/Contract Number:: 1R01AI104589; 200-2009-32597; GM103493; AC05-76RL01830; AC05-76RLO 1830

Resource Type:: Published Article

Journal Name:: Tuberculosis

Additional Journal Information:: Journal Volume: none; Journal Issue: none; Journal ID: ISSN 1472-9792

Publisher:: Elsevier

Country of Publication:: United States

Language:: English

Subject:: 60 APPLIED LIFE SCIENCES; Ion mobility spectrometry; Proteomics; Tuberculosis; Antibiotic treatment

Citation Formats


                    Kedia, Komal, Wendler, Jason, Baker, Erin S., Burnum-Johnson, Kristin E., Jarsberg, Leah G., Stratton, Kelly G., Wright, Aaron T., Piehowski, Paul D., Gritsenko, Marina A., Lewinsohn, David M., Sigal, George B., Weiner, Marc H., Smith, Richard D., Jacobs, Jon M., and Nahid, Payam. Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis.  United States: N. p., 2018. 
        Web.  doi:10.1016/J.TUBE.2018.07.005.

Copy to clipboard


                    Kedia, Komal, Wendler, Jason, Baker, Erin S., Burnum-Johnson, Kristin E., Jarsberg, Leah G., Stratton, Kelly G., Wright, Aaron T., Piehowski, Paul D., Gritsenko, Marina A., Lewinsohn, David M., Sigal, George B., Weiner, Marc H., Smith, Richard D., Jacobs, Jon M., & Nahid, Payam. Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis.  United States.  doi:10.1016/J.TUBE.2018.07.005.

Copy to clipboard


                    Kedia, Komal, Wendler, Jason, Baker, Erin S., Burnum-Johnson, Kristin E., Jarsberg, Leah G., Stratton, Kelly G., Wright, Aaron T., Piehowski, Paul D., Gritsenko, Marina A., Lewinsohn, David M., Sigal, George B., Weiner, Marc H., Smith, Richard D., Jacobs, Jon M., and Nahid, Payam. Wed .  
        "Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis".  United States.  doi:10.1016/J.TUBE.2018.07.005.

Copy to clipboard


                    
@article{osti_1461904,

  title        = {Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis},

  author       = {Kedia, Komal and Wendler, Jason and Baker, Erin S. and Burnum-Johnson, Kristin E. and Jarsberg, Leah G. and Stratton, Kelly G. and Wright, Aaron T. and Piehowski, Paul D. and Gritsenko, Marina A. and Lewinsohn, David M. and Sigal, George B. and Weiner, Marc H. and Smith, Richard D. and Jacobs, Jon M. and Nahid, Payam},

  abstractNote = {Here, the monitoring of TB treatments in clinical practice and clinical trials relies on traditional sputum-based culture status indicators at specific time points. Accurate, predictive, blood-based protein markers would provide a simpler and more informative view of patient health and response to treatment. We utilized sensitive, high throughput multiplexed ion mobility-mass spectrometry (IM-MS) to characterize the serum proteome of TB patients at the start of and at 8 weeks of rifamycin-based treatment. We sought to identify treatment specific signatures within patients as well as correlate the proteome signatures to various clinical markers of treatment efficacy. Serum samples were collected from 289 subjects enrolled in CDC TB Trials Consortium Study 29 at time of enrollment and at the end of the intensive phase (after 40 doses of TB treatment). Serum proteins were immunoaffinity-depleted of high abundant components, digested to peptides and analyzed for data acquisition utilizing a unique liquid chromatography IM-MS platform (LC-IM-MS). Linear mixed models were utilized to identify serum protein changes in the host response to antibiotic treatment as well as correlations with culture status end points. A total of 10,137 peptides corresponding to 872 proteins were identified, quantified, and used for statistical analysis across the longitudinal patient cohort. In response to TB treatment, 244 proteins were significantly altered. Pathway/network comparisons helped visualize the interconnected proteins, identifying up regulated (lipid transport, coagulation cascade, endopeptidase activity) and down regulated (acute phase) processes and pathways in addition to other cross regulated networks (inflammation, cell adhesion, extracellular matrix). Detection of possible lung injury serum proteins such as HPSE, significantly downregulated upon treatment. Analyses of microbiologic data over time identified a core set of serum proteins (TTHY, AFAM, CRP, RET4, SAA1, PGRP2) which change in response to treatment and also strongly correlate with culture status. A similar set of proteins at baseline were found to be predictive of week 6 and 8 culture status.},

  doi          = {10.1016/J.TUBE.2018.07.005},

  journal      = {Tuberculosis},

  number       = none,

  volume       = none,

  place        = {United States},

  year         = {2018},

  month        = {7}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
DOI: 10.1016/J.TUBE.2018.07.005

Other availability

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

Journal Article Kedia, Komal ; Wendler, Jason ; Baker, Erin S. ; ... - Tuberculosis

Here, the monitoring of TB treatments in clinical practice and clinical trials relies on traditional sputum-based culture status indicators at specific time points. Accurate, predictive, blood-based protein markers would provide a simpler and more informative view of patient health and response to treatment. We utilized sensitive, high throughput multiplexed ion mobility-mass spectrometry (IM-MS) to characterize the serum proteome of TB patients at the start of and at 8 weeks of rifamycin-based treatment. We sought to identify treatment specific signatures within patients as well as correlate the proteome signatures to various clinical markers of treatment efficacy. Serum samples were collected frommore »« less
DOI: 10.1016/J.TUBE.2018.07.005

Full Text Available
Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

Journal Article Kedia, Komal ; Wendler, Jason P. ; Baker, Erin S. ; ... - Tuberculosis

Rationale: The monitoring of TB treatments in clinical practice and clinical trials relies on traditional sputum-based culture status indicators at specific time points. Accurate, predictive, blood-based protein markers would provide a simpler and more informative view of patient health and response to treatment. Objective: We utilized sensitive, high throughput multiplexed ion mobility-mass spectrometry (IM-MS) to characterize the serum proteome of TB patients at the start of and at 8 weeks of rifamycin-based treatment. We sought to identify treatment specific signatures within patients as well as correlate the proteome signatures to various clinical markers of treatment efficacy. Methods: Serum samples weremore »« less
DOI: 10.1016/j.tube.2018.07.005
Advancing the High Throughput Identification of Liver Fibrosis Protein Signatures Using Multiplexed Ion Mobility Spectrometry

Journal Article Baker, Erin Shammel ; Burnum-Johnson, Kristin E. ; Jacobs, Jon M. ; ... - Molecular and Cellular Proteomics, 13(4):1119-1127

Rapid diagnosis of disease states using less invasive, safer, and more clinically acceptable approaches than presently employed is an imperative goal for the field of medicine. While mass spectrometry (MS)-based proteomics approaches have attempted to meet these objectives, challenges such as the enormous dynamic range of protein concentrations in clinically relevant biofluid samples coupled with the need to address human biodiversity have slowed their employment. Herein, we report on the use of a new platform that addresses these challenges by coupling technical advances in rapid gas phase multiplexed ion mobility spectrometry (IMS) separations [1, 2] with liquid chromatography (LC) andmore »« less
DOI: 10.1074/mcp.M113.034595
Native mass spectrometry and ion mobility characterize the orange carotenoid protein functional domains

Journal Article Zhang, Hao ; Liu, Haijun ; Lu, Yue ; ... - Biochimica et Biophysica Acta - Bioenergetics
Cited by 9
DOI: 10.1016/j.bbabio.2016.02.015
Native mass spectrometry and ion mobility characterize the orange carotenoid protein functional domains

Journal Article Zhang, Hao ; Liu, Haijun ; Lu, Yue ; ... - Biochimica et Biophysica Acta - Bioenergetics
Cited by 9
DOI: 10.1016/j.bbabio.2016.02.015

Similar Records